Literature DB >> 25278492

Alpha synuclein is transported into and out of the brain by the blood-brain barrier.

Yu-Ting Sui1, Kristin M Bullock2, Michelle A Erickson2, Jing Zhang1, W A Banks3.   

Abstract

Alpha-synuclein (α-Syn), a small protein with multiple physiological and pathological functions, is one of the dominant proteins found in Lewy Bodies, a pathological hallmark of Lewy body disorders, including Parkinson's disease (PD). More recently, α-Syn has been found in body fluids, including blood and cerebrospinal fluid, and is likely produced by both peripheral tissues and the central nervous system. Exchange of α-Syn between the brain and peripheral tissues could have important pathophysiologic and therapeutic implications. However, little is known about the ability of α-Syn to cross the blood-brain barrier (BBB). Here, we found that radioactively labeled α-Syn crossed the BBB in both the brain-to-blood and the blood-to-brain directions at rates consistent with saturable mechanisms. Low-density lipoprotein receptor-related protein-1 (LRP-1), but not p-glycoprotein, may be involved in α-Syn efflux and lipopolysaccharide (LPS)-induced inflammation could increase α-Syn uptake by the brain by disrupting the BBB. Published by Elsevier Inc.

Entities:  

Keywords:  Alpha-synuclein; Blood–brain barrier; LRP-1; Parkinson's disease; p-Glycoprotein

Mesh:

Substances:

Year:  2014        PMID: 25278492      PMCID: PMC4378645          DOI: 10.1016/j.peptides.2014.09.018

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  61 in total

Review 1.  The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.

Authors:  R Deane; A Sagare; B V Zlokovic
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

2.  Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.

Authors:  Takahiko Tokuda; Sultan A Salem; David Allsop; Toshiki Mizuno; Masanori Nakagawa; Mohamed M Qureshi; Joseph J Locascio; Michael G Schlossmacher; Omar M A El-Agnaf
Journal:  Biochem Biophys Res Commun       Date:  2006-08-14       Impact factor: 3.575

3.  Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

Authors:  Ronald B DeMattos; Kelly R Bales; David J Cummins; Steven M Paul; David M Holtzman
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

4.  Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis.

Authors:  Micha M M Wilhelmus; John G J M Bol; Elise S Van Haastert; Annemieke J M Rozemuller; Guojun Bu; Benjamin Drukarch; Jeroen J M Hoozemans
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

5.  Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.

Authors:  Andisheh Eslamboli; Marina Romero-Ramos; Corinna Burger; Tomas Bjorklund; Nicholas Muzyczka; Ronald J Mandel; Harry Baker; Rosalind M Ridley; Deniz Kirik
Journal:  Brain       Date:  2007-02-15       Impact factor: 13.501

6.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

7.  The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy.

Authors:  P H Lee; G Lee; H J Park; O Y Bang; I S Joo; K Huh
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

8.  Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.

Authors:  D W Miller; S M Hague; J Clarimon; M Baptista; K Gwinn-Hardy; M R Cookson; A B Singleton
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

Review 9.  Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease.

Authors:  Paul M Carvey; Qin Chang; Jack W Lipton; Zaodung Ling
Journal:  Front Biosci       Date:  2003-09-01

10.  Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease.

Authors:  W A Banks; S M Robinson; S Verma; J E Morley
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  55 in total

Review 1.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 2.  Age-associated physiological and pathological changes at the blood-brain barrier: A review.

Authors:  Franciska Erdő; László Denes; Elizabeth de Lange
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-11       Impact factor: 6.200

3.  Interferon-γ Potentiates α-Synuclein-induced Neurotoxicity Linked to Toll-like Receptors 2 and 3 and Tumor Necrosis Factor-α in Murine Astrocytes.

Authors:  Jintang Wang; Zheng Chen; Jeremy D Walston; Peisong Gao; Maolong Gao; Sean X Leng
Journal:  Mol Neurobiol       Date:  2019-05-16       Impact factor: 5.590

Review 4.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 5.  Parkinson's disease: Are gut microbes involved?

Authors:  Yogesh Bhattarai; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

Review 6.  Immunoadolescence: Neuroimmune development and adolescent behavior.

Authors:  Heather C Brenhouse; Jaclyn M Schwarz
Journal:  Neurosci Biobehav Rev       Date:  2016-05-31       Impact factor: 8.989

Review 7.  New windows into the brain: Central nervous system-derived extracellular vesicles in blood.

Authors:  Min Shi; Lifu Sheng; Tessandra Stewart; Cyrus P Zabetian; Jing Zhang
Journal:  Prog Neurobiol       Date:  2019-01-25       Impact factor: 11.685

8.  α-Synuclein activates innate immunity but suppresses interferon-γ expression in murine astrocytes.

Authors:  Jintang Wang; Zheng Chen; Jeremy D Walston; Peisong Gao; Maolong Gao; Sean X Leng
Journal:  Eur J Neurosci       Date:  2018-05-19       Impact factor: 3.386

Review 9.  Brain-gut-microbiota axis in Parkinson's disease.

Authors:  Agata Mulak; Bruno Bonaz
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

10.  Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson's disease.

Authors:  Congcong Sun; Zhenxiang Zhao; Wenfei Yu; Mingshu Mo; Chengyuan Song; Youfeng Si; Yiming Liu
Journal:  Ann Transl Med       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.